What Will Move The Needle?

In January of 2023, the federal government changed the rules for prescribing buprenorphine.;The new rules increased the cap on the number of consumers using buprenorphine that an individual prescribing clinician could have in their practice and eliminated some training requirements (see;Feds To Ease Regulations Affecting Access To Opioid Addiction Treatment). As a result, any clinician with a current DEA registration that includes Schedule III authority can prescribe buprenorphine for opioid use disorder (OUD) and the maximum number of consumers with substance use disorder (SUD) who can be treated at the same time has increased to 275 . . .